Certain defects have been associated with the ASR® Hip Resurfacing System and ASR® XL Acetabular System implants. Attempts were taken by the manufacturer of these devices, DePuy, to withdraw them from the market after a British study indicated that patients being implanted with the ASR® system would likely need to have additional corrective surgery within 5 years (which is double the normal rate for similar devices).
Patients are at even greater risk for corrective surgery if they are:
- Female; or
- Implanted with a joint head size of less than 50mm in diameter
Problems started arising with the ASR® Hip Resurfacing System and ASR® XL Acetabular System about 5 years ago when a significant number of the devices failed prematurely and multiple complaints were made to the FDA. These failures caused numerous people to have to undergo painful curative procedures.
If you or a loved one had to endure corrective surgery after implantation of the ASR® Hip Resurfacing System or ASR® XL Acetabular System please contact one of our experienced defective medical devices lawyers today. We have the knowledge, resources and experience to assist you in obtaining fair and just compensation.
DePuy ASR® and ASR® are registered trademarks of DePuy Orthopaedics, a subsidiary of Johnson and Johnson.
Please call us today at 440.248.8811 or fill out the contact form below for a free review of your claim.